Oxford Biomedica - COVID vaccine and Kymriah news encouraging
Oxford Biomedica (OXB) announced that it has signed a new three-year Master Services and Development Agreement with AstraZeneca (AZN) for future...
673 Views
Oxford Biomedica - Driving innovation in a thriving CGT industry
Oxford Biomedica (OXB) is one of few global lentiviral vector manufacturers with capacity in a thriving cell and gene therapy industry, and its...
566 Views
Video: Oxford Biomedica – executive interview
Why are investors buying into Oxford Biomedica (LN:OXB)? In this interview, BBC broadcaster Vivienne Parry OBE asks CEO John Dawson why Oxford...
617 Views
Oxford Biomedica - Vector innovation key to cell and gene evolution
Oxford Biomedica (OXB) is a pioneer and global leader in the development and manufacture of commercial-scale lentiviral vectors (LVVs), a critical...
245 Views
Oxford Biomedica - COVID-19 vaccine collaboration agreement
Oxford Biomedica (OXB) has signed a five-year collaboration agreement with the Vaccines Manufacturing and Innovation Centre (VMIC), a non-profit...
112 Views